Multiple category verbal fluency in mild cognitive impairment and correlation with CSF biomarkers for Alzheimer's disease

被引:33
|
作者
Mirandez, Roberta M. [1 ]
Aprahamian, Ivan [1 ]
Talib, Leda L. [1 ]
Forlenza, Orestes V. [1 ]
Radanovic, Marcia [1 ]
机构
[1] Univ Sao Paulo, Fac Med, Dept & Inst Psychiat, Lab Neurosci LIM 27, Rua Dr Ovidio Pires de Campos 785,3rd Floor, BR-05403010 Sao Paulo, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
mild cognitive impairment; verbal fluency; aging; CSF; biomarkers; OLDER-ADULTS; PERFORMANCE; DIAGNOSIS;
D O I
10.1017/S1041610217000102
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background: Verbal fluency (VF) tasks are widely used in neuropsychological evaluations, as a measure of executive/semantic dysfunction. The revised criteria for Alzheimer's disease (AD) diagnosis (National Institute on Aging and the Alzheimer Association, 2011) incorporating biomarkers has increased the interest in finding algorithms that combine neuropsychological and biomarkers features to better predict conversion from mild cognitive impairment (MCI) to AD. Our aim was to compare the most frequently used VF categories to determine which best discriminated cognitively healthy elderly from MCI patients, and whether cerebrospinal fluid (CSF) biomarkers levels (A beta 42, P-tau, T-tau, and A beta 42/P-tau) correlated with patient's performance in MCI. Methods: We studied 37 cognitively healthy elderly and 30 MCI patients in five VF tasks (animal, fruits, means of transportation, FAS-COWA, and verbs); 23 controls and 19 MCI patients had their CSF biomarkers for AD determined. Results: MCI group performed worse than controls in all VF tasks (p < 0.0001). The cut-off scores were: 14 (animals) (AUC = 0.794), 12 (fruits and means of transportation) (AUC = 0.740 and 0.719, respectively), 41 (FAS) (AUC = 0.744), and 11 (verbs) (AUC = 0.700). The model "animal plus FAS-COWA" was the best to discriminate both groups (AUC = 0.833) (all p < 0.05). MCI produced fewer words than controls in the second-half of the task for all categories (p < 0.001). T-tau levels were negatively correlated to animal fluency (r=-0.485, p = 0.035), and showed a trend for negative correlation with fruits fluency (r=-0.4429, p = 0.057). Conclusions: Animal fluency alone and combined to FAS-COWA was slightly superior in discriminating controls from MCI (p < 0.001), and correlated to T-tau levels.
引用
收藏
页码:949 / 958
页数:10
相关论文
共 50 条
  • [1] Verbal Fluency Patterns in Mild Cognitive Impairment and Alzheimer's Disease
    Rinehardt, Eric
    Eichstaedt, Katie
    Schinka, John A.
    Loewenstein, David A.
    Mattingly, Michelle
    Fils, Jean
    Duara, Ranjan
    Schoenberg, Mike R.
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2014, 38 (1-2) : 1 - 9
  • [2] Novel CSF biomarkers for Alzheimer's disease and mild cognitive impairment
    Hu, William T.
    Chen-Plotkin, Alice
    Arnold, Steven E.
    Grossman, Murray
    Clark, Christopher M.
    Shaw, Leslie M.
    Pickering, Eve
    Kuhn, Max
    Chen, Yu
    McCluskey, Leo
    Elman, Lauren
    Karlawish, Jason
    Hurtig, Howard I.
    Siderowf, Andrew
    Lee, Virginia M. -Y.
    Soares, Holly
    Trojanowski, John Q.
    ACTA NEUROPATHOLOGICA, 2010, 119 (06) : 669 - 678
  • [3] CSF biomarkers for mild cognitive impairment and early Alzheimer's disease
    Andreasen, N
    Blennow, K
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2005, 107 (03) : 165 - 173
  • [4] Novel CSF biomarkers for Alzheimer’s disease and mild cognitive impairment
    William T. Hu
    Alice Chen-Plotkin
    Steven E. Arnold
    Murray Grossman
    Christopher M. Clark
    Leslie M. Shaw
    Eve Pickering
    Max Kuhn
    Yu Chen
    Leo McCluskey
    Lauren Elman
    Jason Karlawish
    Howard I. Hurtig
    Andrew Siderowf
    Virginia M.-Y. Lee
    Holly Soares
    John Q. Trojanowski
    Acta Neuropathologica, 2010, 119 : 669 - 678
  • [5] Biomarkers of Alzheimer's disease in the CSF of patients with mild cognitive impairment
    Monge-Argiles, J. A.
    Munoz-Ruiz, C.
    Pampliega-Perez, A.
    Gomez-Lopez, M. J.
    Sanchez-Paya, J.
    Rodriguez-Borja, E.
    Ruiz-Vegara, M.
    Montoya-Gutierrez, J.
    Leiva-Santana, C.
    JOURNAL OF NEUROLOGY, 2010, 257 : S166 - S166
  • [6] Similar Verbal Fluency Patterns in Amnestic Mild Cognitive Impairment and Alzheimer's Disease
    Teng, Edmond
    Leone-Friedman, Judith
    Lee, Grace J.
    Woo, Stephanie
    Apostolova, Liana G.
    Harrell, Shelly
    Ringman, John M.
    Lu, Po H.
    ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2013, 28 (05) : 400 - 410
  • [7] CSF Biomarkers in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
    Papaliagkas, Vasileios
    Kalinderi, Kallirhoe
    Vareltzis, Patroklos
    Moraitou, Despoina
    Papamitsou, Theodora
    Chatzidimitriou, Maria
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (10)
  • [8] CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
    Mattsson, Niklas
    Zetterberg, Henrik
    Hansson, Oskar
    Andreasen, Niels
    Parnetti, Lucilla
    Jonsson, Michael
    Herukka, Sanna-Kaisa
    van der Flier, Wiesje M.
    Blankenstein, Marinus A.
    Ewers, Michael
    Rich, Kenneth
    Kaiser, Elmar
    Verbeek, Marcel
    Tsolaki, Magda
    Mulugeta, Ezra
    Rosen, Erik
    Aarsland, Dag
    Visser, Pieter Jelle
    Schroeder, Johannes
    Marcusson, Jan
    de Leon, Mony
    Hampel, Harald
    Scheltens, Philip
    Pirttilae, Tuula
    Wallin, Anders
    Jonhagen, Maria Eriksdotter
    Minthon, Lennart
    Winblad, Bengt
    Blennow, Kaj
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (04): : 385 - 393
  • [9] Biomarkers of mild cognitive impairment and Alzheimer's disease
    Tang, Bor Luen
    Kumar, Rajeev
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2008, 37 (05) : 406 - 410
  • [10] CSF cortisol in Alzheimer's disease and mild cognitive impairment
    Popp, Julius
    Schaper, Karsten
    Koelsch, Heike
    Cvetanovska, Gabriela
    Rommel, Fatima
    Klingmueller, Dietrich
    Dodel, Richard
    Wuellner, Ullrich
    Jessen, Frank
    NEUROBIOLOGY OF AGING, 2009, 30 (03) : 498 - 500